Synthesis, antitumor and antiviral properties of some 1,2,4-triazole derivatives

Farmaco

Volumn 59, Issue 10, 2004, Pages 775-783

  Al Soud, Yaseen A ^a   Al Dweri, Mohammad N ^a   Al Masoudi, Najim A ^b  

^a AL AL BAYT UNIVERSITY   (Jordan)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

(1 ETHYL 5 METHYL 1H [1,2,4]TRIAZOL 3 YL)ACETIC ACID BENZYLIDENE HYDRAZIDE; (1 ETHYL 5 METHYL 1H [1,2,4]TRIAZOL 3 YL)ACETIC ACID CYCLOPENTYLIDIN 2 YLMETHYLENE HYDRAZIDE; (1 ETHYL 5 METHYL 1H [1,2,4]TRIAZOL 3 YL)ACETIC ACID FURAN 2 YLMETHYLENE HYDRAZIDE; (1 ETHYL 5 METHYL 1H [1,2,4]TRIAZOL 3 YL)ACETIC ACID ISOPROPYLIDENE HYDRAZIDE; (1,5 DIETHYL 1H [1,2,4]TRIAZOL 3 YL)ACETIC ACID ISOPROPYLIDENE HYDRAZIDE; (6,7,8,9 TETRAHYDRO 5H [1,2,4] TRIAZOLO[1,5 A]AZEPIN 2 YL)ACETIC ACID; 1 ETHYL 5 METHYL 3 (4 CHLOROBENZYL 1 YL) 1H 1,2,4 TRIAZOLE; 1,5 DIMETHYL 3 (5 ETHYLSULFANYL 4 N PHENYL 1H [1,2,4]TRIAZOL 3 YLMETHYLENE) 1H [1,2,4]TRIAZOLE; 1,5 DIMETHYL 3 (5 MERCAPTO 4 N PHENYL 1H [1,2,4]TRIAZOL 3 YLMETHYLENE) 1H [1,2,4]TRIAZOLE; 2 (6,7,8,9 TETRAHYDRO 5H [1,2,4]TRIAZOLO[1,5 A]AZEPIN 2 YLMETHYLENE) 5 ETHYLMERCAPTO 1,3,4 OXADIAZOLE; 4 (4 METHOXYPHENYL 1H [1,2,4]TRIAZOLO[1,5 A]PYRIDIN 2 YLMETHYLENE)[1,2,4] TRIAZOLE 3 THIONE; 5 (1 ETHYL 5 METHYL 1H [1,2,4]TRIAZOL 3 YLMETHYLENE) 3H [1,3,4]OXADIAZOLE 2 THIONE; 5 (1,5 DIETHYL 1H [1,2,4]TRIAZOL 3 YLMETHYLENE) 3H [1,3,4]OXADIAZOL 2 YLAMINE; 5 (1,5 DIETHYL 1H [1,2,4]TRIAZOL 3 YLMETHYLENE) 3H [1,3,4]OXADIAZOLE 2 THIONE; 5 (6,7,8,9 TETRAHYDRO 5H [1,2,4]TRIAZOLO[1,5 A]AZEPIN 2 YLMETHYLENE)[1,3,4]OXADIAZOLE 2 THIONE; [1 (1 ETHYL 5 METHYL 1H [1,2,4]TRIAZOL 3 YL)BENZYL]INDOLE; [1 (6,7,8,9 TETRAHYDRO 5H [1,2,4]TRIAZOLO[1,5 A]AZEPIN 2 YL)BENZYL]INDOLE; ACETIC ACID DERIVATIVE; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SCREENING; DRUG SYNTHESIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARAINFLUENZA VIRUS 3; REOVIRUS; SINDBIS VIRUS; TOROVIRUS;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CELL LINE, TUMOR; HUMANS; TRIAZOLES;

EID: 5044249936     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2004.05.006     Document Type: Article

References (63)

1. Tsukuda T., Shiratori Y., Watanabe M., Ontsuka H., Hattori K., Shirai M., and Shimma N. Modeling, synthesis and biological activity of novel antifungal agents (1) Bioorg. Med. Chem. Lett. 8 1998 1819 1824
2. Witkoaski J.T., Robins R.K., Sidwell R.W., and Simon L.N. Design, synthesis and broad spectrum antiviral activity of 1-β-d-ribofuranosyl-1,2, 4-triazole-3-carboxamide and related nucleosides J. Med. Chem. 15 1972 1150 1154
3. Heubach G., Sachse B., and Buerstell H. 1,2,4-Triazole derivatives Ger. Offen. 2 1979 826,760
4. Chem. Abstr. 92 1975 181200 h
5. Tanaka G. Triazole derivatives Japan Kokai 973 1974 7495
6. Chem. Abstr. 82 1975 156320h
7. Griffin D.A., and Mannion S.K. Preparation of substituted triazolylbutanoates as plant growth regulators Eur. Pat. Appl. EP 1986 199,474
8. Chem. Abstr. 106 1987 98120u
9. Hanna N.B., Dimitrijevich S.D., Larson S.B., Robsin R.K., and Revankar G.R. Synthesis and single-crystal X-ray diffraction studies of 1-β-d-ribofuranosyl-1,2,4-triazole-3-sulfonamide and certain related nucleosides J. Heterocycl. Chem. 25 1988 1857 1868
10. Jenkins T.C., Stratford I.J., and Stephens M.A. 3-Nitro-1,2,4-triazoles as hypoxia-selective agents Anticancer Drug Des. 4 1989 145 160
11. Husain M.I., and Amir M. Synthesis of some new substituted thiosemicarbazides and triazoles as possible anticonvulsants J. Indian Chem. Soc. 63 1986 317 319
12. Chem. Abstr. 106 1987 106 176272m
13. Chiu S.-H.L., and Huskey S.-E.W. Species differences in N-glucuronidation Drug Metabol. Dispos. 26 1998 838 847
14. Eliott R., Sunley R.L., and Griffin D.A. Preparation of plant growth regulant triazoles and imidazoles UK Pat Appl GB 1986 2 175,301
15. Chem. Abstr. 107 1987 134310n
16. Chaaban I., and Oji O.O. Synthesis and preliminary antibacterial activity of 3-(2-arylamino-1,3,4-thiadiazole-5-yl)-4-hydroxy-4- substitutedsulfamoylazobenzenes J. Indian Chem. Soc. 61 1984 523 525
17. Chem. Abstr. 102 1985 62157q
18. Omar A.M.E., and AboulWafa O.M. Synthesis and anticonvulsant properties of a novel series of 2-substituted amino-5-aryl-1,3,4-oxadiazole derivatives J. Heterocycl. Chem. 21 1984 1415 1417
19. Francois C., and Claudine J. 4H-1,2,4-Triazole derivatives and their use as medicines Fr Patent 1984 2 539,127
20. Chem. Abstr. 102 1985 95677n
21. Beasley S.C., Cooper N., Gowers L., Gregory J.P., Haughan A.A.F., Hellewell P.G., Macar D., Miotla J., Montana J.G., Morgan T., Taylor R., Runcie K.A., Tuladhar B., and Warneck J.B.H. Syntheses and evaluation of a novel series of phosphodiestrase IV inhibitors. A potential treatment for asthma Bioorg. Med. Chem. Lett. 8 1998 2629 2634 references therein
22. de Brito F.B., Sounss J.E., and Warne P.J. Type phosphodiesterase inhibitors and their potential in the treatment of inflammatory diseases Emerg. Drugs 2 1997 249 268
23. Chem. Abstr. 127 1997 12795s
24. Giembycz M.A., Dent G., and Sounss J.E. Review: theophyline and isoenzyme-selective phosphodiestrase inhibitors Allerg. Allerg. Dis. 1 1997 531 567
25. Chem. Abstr. 127 1997 75418s
26. Goldsmith R.S. Review of Medical Pharmacology fifth ed 1974 634
27. Sathi G., Gujrati I.P.V.R., Nath C., Agrawal J.C., Bhargava K.P., and Shanker K. Synthesis and pharmacological evaluation of new ethyl esters of N-acylamino acids as CNS agents Pharmazie 315 1982 603 609
28. Dufour C. Monoamine oxidase inhibitory theophyllineacethydrazides, Fr Chem. Abstr. 71 1968 1,548,987 1969, 81426j
29. Mir I., Siddiqui M.T., and Comrie A.M. Antituberculosis agents. Part II α-[5-(2-furyl)-1,3,4-oxadiazol-2-yl-thio)acetohydrazide and related compounds J. Chem. Soc. C 1971 2798 2799
30. Qian X., and Zhang R. Syntheses and insecticidal activities of novel 2,5-disubstituted 1,3,4-oxadiazoles J. Chem. Tech. Biotechnol. 67 1996 124 130
31. Zhang R., and Qian X. Synthesis and bioactivity of 2,5-disubstituted-1,3, 4-oxadiazoles and their N,N′-diacylhydrazine precursors Yingyong Huaxue 13 1996 5 9
32. Chem. Abstr. 126 1997 47158t
33. Zhang R., Qian X., Li Z., and Z. Synthesis and characterization of 2-amino-5-aryl-1,3,4-oxadiazoles containing trifluoroethoxy group Flourine Chem. 93 1999 39 43
34. Sahin G., Palaska E., Ekizoǧlu M., and Özalp M. Farmaco 57 2002 539 542
35. Hill J., and J. Storr R.C. The Comprehensive Heterocyclic Chem II. 1996 Pergamon, Elsevier Science Ltd Oxford 285 For biological activity of 1,3,4-oxadiazoles, see (chapter 4.06)
36. For biological activity of 1,2,4-triazoles, see: p 162, 163 (chapter 4.02).
37. Bush J.A., Long B.H., Catino J.J., Bradner W.T., and Tomita K. Production and biological activity of Rebeccamycin, a novel antitumor agent J. Antibiotics 40 1987 668 678 and references therein
38. Mujagic H., Chen S.-S., Geist R., Occhipinti S.J., Conger B.M., Smith C.A., Schuette W.H., and Schackney S.E. Effects of Vincristine on cell survival, cell cycle progression, and miotic accumulation in asynchronously growing Sarcoma 180 cells Cancer Res. 43 1983 3591 3597
39. Romero D.L., Olmsted R.A., Poel T.J., Morge R.A., Biles C., Keiser B.J., Kopta L.A., Friis J.M., Hosley J.D., Stefanski K.J., Wishka D.G., Evans D.B., Morris J., Stehle R.G., Sharma S.K., Yagi Y., Voorman R.L., Adams W.J., and Tarpley W.G. Targeting Delaviridine/Ateviridine resistance HIV-1, 2: Identification of (alkylamino)piperidine-containing bis(heteroaryl)piperazines as broad spectrum reverse trascriptase inhibitors J. Med. Chem. 39 1996 3769 3789
40. Al-Masoudi N.A., Hassan N.A., Al-Soud Y.A., Schmidt P., Gaafer A.E-D.M., Weng M., Marino S., Schoch A., Amer A., and Jochims J.C. Synthesis of C- and N-nucleosides from 1-aza-2-azoniaellene and 1,3-diaza-2-azoniaaallene salts J. Chem. Soc. Perkin Trans. 1 1998 947 953
41. Al-Soud Y.A., Al-Masoudi W.A., El-Halawa R.A., Al-Masoudi N.A., and N. A. Synthesis and antiviral activity of some 1,2,4-triazole C-nucleosides from 1-(chloroalkyl)-1-aza-2-azoniaallene salts Nucleos. Nucleot. 18 1999 1985 1994
42. Al-Masoudi N.A., Al-Soud Y.A., and Geyer A. Synthesis and spectroscopic analysis some acyclic C-nucleosides and the homo-C-analogues from 1-(chloroalkyl)-1-aza-2-azoniaallene salts Tetrahedron 55 1999 751 758
43. Al-Soud Y.A., and Al-Masoudi N.A. Synthesis and antiviral activity of some 1-(1,5-dialkyl-1H-1,2,4-triazol-3-yl)thymidines Arch. Pharm. Pharm. Med. Chem. 332 1999 143 144
44. Al-Soud Y.A., Al-Masoudi N.A., and Lagoja I.M. Synthesis and reactions of 1,5- and 1,3-dialkyl derivatives of (D-manno-pentitol-1-yl)-1H-1,2,4-triazole nucleosides derived from 1-(chloroalkyl)-1-aza-2-azoniaallene salts Carbohydr. Res. 318 1999 67 74
45. Al-Soud Y.A., and Al-Masoudi N.A. Synthesis and antitumor activity of some new phthalimide analogues Pharmazie 56 2001 372 375
46. Al-Soud Y.A., Halah R.F., and Al-Masoudi N.A. Synthesis of 1-[4-(1,5-disubstituted-1H-1,2,4-triazol-3-yl)benzyl]-1H-indoles and 5,6-dihaloquinolones as potential antitumor agents Org. Prep. Proced. Int. (OPPI) 34 2002 648 664
47. Al-Soud Y.A., Al-Masoudi N.A., and Ferwanah A.E.-R.S. New potential antitumor agents: 1,2,4-triazoles bearing benzotriazoles, acetoxyhydrazides, 5-mercapto-1,2,4-triazoles and sugar hydrazone analogues Bioorg. Med. Chem. 11 2003 1701 1708
48. Al-Soud Y.A., and Al-Masoudi N.A. Synthesis of 3′-1,2,4-triazolo- and 3′-1,3,4-thiadia-zoliminothymidines Heteroatom. Chem. 14 2003 298 303
49. Al-Soud Y.A., and Al-Masoudi N.A. DNA-directed alkylating agents: synthesis, antitumor activity and DNA affinity of bis-N,N′-trisubstituted 1,2,4-triazolo-piprazines Farmaco 59 2004 41 46
50. Wang Q., Jochims J.C., Köhlbrandt St., Dahlenburg L., Al-Talib M., Hamed A., and Ismail A.E. 1,2,4-Triazolium salts from the reaction of 1-aza-2-azoniaallene salts with nitriles Synthesis 1992 710 718
51. Wang Q., Al-Talib M., and Jochims J.C. On the reaction of 1-aza-2-azoniaallene salts with acetylenes Chem. Ber. 127 1994 541 547
52. Reid J.R., and Heindel N.D. Improved synthesis of 5-substituted-4-amino- 3-mercapto-4H-1,2,4-triazoles J. Heterocycl. Chem. 13 1976 925 926
53. Willker W., Leibfritz D., Kerssebaum R., and Bermel W. Gradient selection in inverse heteronuclear correlation spectroscopy Mag. Reson. Chem. 31 1993 287 292 and reference therein
54. 13C assignments of coenzyme B12 through the use of new two-dimensional NMR experiments J. Am. Chem. Soc. 108 1986 4285 4294
55. Davis A.L., Keeler J., Laue E.D., and Moskau D.J. Experiments for recording pure-absorption heteronuclear correlation spectra using pulsed field gradients Magn. Reson. 98 1992 207 216
56. Witkowski J.T., Robins R.K., Sidwell R.W., and Simon L.N. Design, synthesis and broad spectrum antiviral activity of 1-β-d-ribofuranosyl-1,2, 4-triazole-3-carboxamide and related nucleosides J. Med. Chem. 15 1972 1150 1154
57. Smith R.A., Knight V., and Smith J.A.D. Clinical Applications of Ribavirin 1994 Academic Press New York
58. Keller P.M., Fyfe J.A., Beauchamp L., Lubbers C.M., Furman P.A., Schaeffer H.J., and Elion G.B. Enzymetic phosphorylation of acyclic nucleoside analoges and correlation with antiherpetic activities Biochem. Parmacol. 30 1981 3071 3077 30
59. Reines E.D., and Gross P.A. Antiviral Agents Med. Clin. North Am 72 1988 691
60. Beauchamp L.M., Serling B.L., Kelsey J.E., Biron J.E., Collins P., Selway J., Lin J.-C., and Schaeffer H.J. Effect of acyclic pyrimidines related to 9-[(1,3-dihydroxy-2-propoxy) methyl]guanines on herpes viruses J. Med. Chem 31 1988 144 149
61. De Clercq E., and Torrence P.F. Nucleoside analogs with selective antiviral activity J. Carbohydr. Nucleos. Nucleot. 5 1978 187 224
62. Monks A., Scudiero D., Skehan P., Shoemaker R., Paull K., Vistica D., Hose C., Langely J., Cronsie P., Vaigro-Wolff A., Gray-Goodrich M., Campell H., Mayo J., and Boyd M.R. Feasibility of a high-flux anticancer drug screen using a divers panel of cultured human tumor cell lines J. Natl. Cancer Inst. 83 1991 757 766
63. Boyd M.R., and Paull K.D. Some practical consideration and application of the National Cancer Institute in vitro anticancer drug screen Drug Devel. Res. 34 1995 91 109